- Home
- ADAP vs CMBM Comparison
ADAP vs CMBM Comparison
Compare ADAP & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- CMBM
- Stock Information
- Founded
- ADAP 2008
- CMBM 2011
- Country
- ADAP United Kingdom
- CMBM United States
- Employees
- ADAP N/A
- CMBM N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- CMBM Radio And Television Broadcasting And Communications Equipment
- Sector
- ADAP Health Care
- CMBM Technology
- Exchange
- ADAP Nasdaq
- CMBM Nasdaq
- Market Cap
- ADAP 21.3M
- CMBM 25.0M
- IPO Year
- ADAP 2015
- CMBM 2019
- Fundamental
- Price
- ADAP $0.08
- CMBM $0.61
- Analyst Decision
- ADAP Hold
- CMBM Buy
- Analyst Count
- ADAP 6
- CMBM 1
- Target Price
- ADAP $1.02
- CMBM $3.00
- AVG Volume (30 Days)
- ADAP 106.3M
- CMBM 224.0K
- Earning Date
- ADAP 11-12-2025
- CMBM 11-06-2025
- Dividend Yield
- ADAP N/A
- CMBM N/A
- EPS Growth
- ADAP N/A
- CMBM N/A
- EPS
- ADAP N/A
- CMBM N/A
- Revenue
- ADAP $65,084,999.00
- CMBM $172,215,000.00
- Revenue This Year
- ADAP N/A
- CMBM N/A
- Revenue Next Year
- ADAP $24.70
- CMBM $17.73
- P/E Ratio
- ADAP N/A
- CMBM N/A
- Revenue Growth
- ADAP N/A
- CMBM N/A
- 52 Week Low
- ADAP $0.04
- CMBM $0.23
- 52 Week High
- ADAP $0.86
- CMBM $1.69
- Technical
- Relative Strength Index (RSI)
- ADAP 41.40
- CMBM 36.47
- Support Level
- ADAP $0.04
- CMBM $0.75
- Resistance Level
- ADAP $0.24
- CMBM $0.87
- Average True Range (ATR)
- ADAP 0.04
- CMBM 0.09
- MACD
- ADAP -0.01
- CMBM -0.03
- Stochastic Oscillator
- ADAP 15.65
- CMBM 3.20
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.